(Q35140847)

6 August 2017

title

In vitro evaluation of optimized liposomes for delivery of small interfering RNA. (English)

1 reference

6 August 2017

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

Tianzhi Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Tracy Bantegui

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Kaitlynn Pike

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Raymond Bloom

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Roger Phipps

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

8 April 2014

1 reference

Journal of Liposome Research

6 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

270-279

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

Recent advances in tumor vasculature targeting using liposomal drug delivery systems.

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Liposomal drug delivery systems: from concept to clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Inhalable liposomes of low molecular weight heparin for the treatment of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Cationic liposomes as carriers for aerosolized formulations of an anionic drug: safety and efficacy study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Interfering with disease: a progress report on siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Liposomes incorporating hydrophobically modified silk fibroin: pH-dependent release

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Delivery materials for siRNA therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

PEG conjugated VEGF siRNA for anti-angiogenic gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

RNAi in clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Solubilization of flurbiprofen into aptamer-modified PEG-PLA micelles for targeted delivery to brain-derived endothelial cells in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Nucleic acid aptamers: clinical applications and promising new horizons

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Role of the VEGF/VEGFR axis in cancer biology and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Lipid-based nanotherapeutics for siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Anti-VEGF/VEGFR therapy for cancer: reassessing the target

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Vascular endothelial growth factor (VEGF), VEGF receptors and their inhibitors for antiangiogenic tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Recent advances with liposomes as pharmaceutical carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Intravenously administered short interfering RNA accumulates in the kidney and selectively suppresses gene function in renal proximal tubules.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Knocking down barriers: advances in siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Advancements in the field of intravaginal siRNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

Comparative studies on chitosan and polylactic-co-glycolic acid incorporated nanoparticles of low molecular weight heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08982104.2014.907306

10.3109/08982104.2014.907306

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24708056%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference